Catalyst Event
Samsung Biologics Co Ltd (207940) · Earnings Release
From Akros K-Manufacturing 50 Index (AKMNF50)
7/29/2026, 12:00:00 AM
Samsung Biologics is scheduled to release its Q2 2026 earnings report on July 29, 2026, as forecasted by financial data providers. High importance is assigned due to the anticipated impact of the first full-quarter contribution from Plant 4 on market expectations forecasted.
Korean Translation
금융정보 제공업체에 따르면 2026년 7월 29일에 2026년 2분기 실적 보고서를 발표할 예정임. 4공장 완전 가동에 따른 실적 변화가 주목되어 높은 중요도로 분류되며 실적 발표가 전망됨.
Related Recent Events
HD HYUNDAI Marine Solution CO LTD (443060) · Earnings Release
The company's Q2 2026 earnings release is scheduled. Importance is estimated as High as earnings announcements can lead to significant price volatility depending on whether the results meet, beat, or miss market expectations scheduled
8/18/2026, 12:00:00 AM
Hyundai Rotem Co (064350) · Earnings Release
2nd quarter 2026 earnings release scheduled. This routine announcement is expected to have a low market impact.
8/18/2026, 12:00:00 AM
Ecopro Co Ltd (086520) · Earnings Release
Ecopro's Q2 2026 earnings release on August 18, 2026, with low market impact estimated for this routine announcement, scheduled
8/18/2026, 12:00:00 AM
Sanil Electric Co Ltd (062040) · Earnings Release
A medium impact is expected as investors monitor the company's growth trajectory for the 2Q 2026 earnings release, scheduled.
8/12/2026, 12:00:00 AM
LIG Defense and Aerospace Co Ltd (079550) · Earnings Release
Medium importance is estimated based on expected market volatility during the reporting period. The company's Q2 2026 earnings release is scheduled.
8/6/2026, 12:00:00 AM
Wonik IPS Co Ltd (240810) · Earnings Release
Low importance estimated as quarterly earnings typically impact price by 1-5%; Q2 2026 earnings release on August 6, 2026, scheduled.
8/6/2026, 12:00:00 AM